Iovance Biotherapeutics
IOVA
#5147
Rank
HK$11.90 B
Marketcap
HK$28.90
Share price
-4.65%
Change (1 day)
5.02%
Change (1 year)

Market capitalization of Iovance Biotherapeutics (IOVA)

Market cap: HK$11.90 Billion

As of March 2026 Iovance Biotherapeutics has a market cap of HK$11.90 Billion. This makes Iovance Biotherapeutics the world's 5147th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Iovance Biotherapeutics from 2010 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$11.90 B36.06%
2025HK$8.75 B-50.1%
2024HK$17.53 B7.92%
2023HK$16.24 B106.25%
2022HK$7.87 B-66.27%
2021HK$23.35 B-55.74%
2020HK$52.76 B93.62%
2019HK$27.25 B218.61%
2018HK$8.55 B88.4%
2017HK$4.53 B35.42%
2016HK$3.35 B15.4%
2015HK$2.90 B41%
2014HK$2.06 B26.37%
2013HK$1.63 B1073.52%
2012HK$0.13 B-77.36%
2011HK$0.61 B-10.78%
2010HK$0.68 B

End of Day market cap according to different sources

On Mar 21st, 2026 the market cap of Iovance Biotherapeutics was reported to be:

HK$11.90 Billion
by Nasdaq info icon info icon
HK$11.90 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Nymox Pharmaceutical
NYMX
HK$0.14 B-98.80% Bahamas
NRC Health
NRC
HK$3.08 B-74.08%๐Ÿ‡บ๐Ÿ‡ธ USA